ReShape Lifesciences News

ReShape Lifesciences | 10-Q: Quarterly report

May 15 16:56 ET

ReShape Lifesciences | S-3: Registration statement for specified transactions by certain issuers

May 9 12:51 ET

ReShape Lifesciences | 8-K: Current report

Apr 10 16:59 ET

ReShape Lifesciences | 8-K: Current report

Apr 10 12:49 ET

ReShape Lifesciences | 8-K: Current report

Apr 4 11:15 ET

ReShape Lifesciences | 10-K: Annual report

Apr 1 17:25 ET

ReShape Lifesciences | 8-K: Current report

Feb 26 16:22 ET

ReShape Lifesciences | DEF 14A: Definitive information statements

Jan 24 11:53 ET

ReShape Lifesciences | 8-K: Current report

Jan 18 00:00 ET

ReShape Lifesciences | SC 13G: Statement of acquisition of beneficial ownership by individuals-Yair Schneid(10.525%)

Jan 17 00:00 ET

ReShape Lifesciences | 3: Initial statement of beneficial ownership of securities-10% Owner Schneid Yair

Jan 16 00:00 ET

ReShape Lifesciences | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Jan 5 00:00 ET

ReShape Lifesciences | 8-K: Current report

Nov 29, 2023 16:05 ET

ReShape Lifesciences: Q3 2023 Earnings Report

Nov 8, 2023 18:19 ET

ReShape Lifesciences | 8-K: Current report

Nov 8, 2023 17:44 ET

ReShape Lifesciences | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer STANKOVICH THOMAS

Nov 8, 2023 16:16 ET

ReShape Lifesciences | 8-K: Current report

Oct 13, 2023 16:42 ET

ReShape Lifesciences | 8-K: Current report

Oct 5, 2023 16:05 ET

ReShape Lifesciences | 424B4: Prospectus

Oct 3, 2023 09:23 ET

ReShape Lifesciences | EFFECT: Others

Oct 2, 2023 00:15 ET